After September’s 5.2% correction, stocks exhibited strength in October, with the S&P 500 returning an impressive 6.6% for the month. Better than expected earnings...
Some experts say we’re in “the golden age of biotechnology.” Scientific advances are opening up possibilities for the treatment and prevention of diseases that...